t
Oxford Biomedica PLC reported the issuance of 2,905 securities under its 2015 Employee Share Option Scheme, 192,609 under its 2015 Long Term Incentive Plan, and 28,200 under its 2015 Deferred Bonus Plan. These allotments occurred during the period from 1 July 2023 to 31 December 2023, with no securities issued under the Sharesave Scheme during this time.
| Date | 2 Jan 2024 |
| Time | 07:00:05 |
| Category | Capital structure |
| ID | 2617Y |
|
Name of applicant: |
OXFORD BIOMEDICA PLC |
|||
|
Name of scheme: |
2015 Employee Share Option Scheme |
|||
|
Period of return: |
From: |
1 July 2023 |
To: |
31 December 2023 |
|
Balance of unallotted securities under scheme(s) from previous return: |
309,426 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
NIL |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
2,905 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
306,521 |
|||
|
|
|
|
|
|
|
Name of applicant: |
OXFORD BIOMEDICA PLC |
|||
|
Name of scheme: |
2015 Long Term Incentive Plan |
|||
|
Period of return: |
From: |
1 July 2023 |
To: |
31 December 2023 |
|
Balance of unallotted securities under scheme(s) from previous return: |
442,977 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
NIL |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
192,609 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
250,368 |
|||
|
|
|
|
|
|
|
Name of applicant: |
OXFORD BIOMEDICA PLC |
|||
|
Name of scheme: |
2015 Deferred Bonus Plan |
|||
|
Period of return: |
From: |
1 July 2023 |
To: |
31 December 2023 |
|
Balance of unallotted securities under scheme(s) from previous return: |
296,272 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
NIL |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
28,200 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
268,072 |
|||
|
|
|
|
|
|
|
Name of applicant: |
OXFORD BIOMEDICA PLC |
|||
|
Name of scheme: |
Sharesave Scheme |
|||
|
Period of return: |
From: |
1 July 2023 |
To: |
31 December 2023 |
|
Balance of unallotted securities under scheme(s) from previous return: |
339,753 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
NIL |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
NIL |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
339,753 |
|||
|
Name of contact: |
Natalie Walter, Company Secretary |
|
Telephone number of contact: |
01865 783000 |